BioMarin Pharmaceutical Inc. (BMRN)

[ghmm]

Rather then buyout rumors could it be people are starting to get excited about potential for BH4 in Uncontrolled Hypertension? Results of the 2A study will come within a month.

I think we get success in at least one of the cardio vascular indications the company is pursuing. I really like the way they are doing things with multiple Phase 2's and things such as dividing the diabetic vs. non-diabetics. The company is really giving shareholders many shots on goal at relatively low risk.

I really like the company pursuing BH4 in sickle cell disease too! Being an Orphan indication the 7/10 year exclusivity and similar population size as PKU make it a valuable niche.

BH4 could really be a gold mine for the company! FYI here is a link for more info.
http://www.bh4.org/BH4_Start.asp

I say forget about selling the company for a while! We still have a way to go!!